Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday . The stock traded as low as $4.52 and last traded at $4.58, with a volume of 777233 shares changing hands. The stock had previously closed at $4.40.
Evotec Stock Performance
The stock’s 50-day moving average is $3.88 and its 200-day moving average is $4.40. The firm has a market capitalization of $1.40 billion, a price-to-earnings ratio of 10.37 and a beta of 0.98. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Stories
- Five stocks we like better than Evotec
- Airline Stocks – Top Airline Stocks to Buy Now
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- ETF Screener: Uses and Step-by-Step Guide
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Business Services Stocks Investing
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
